Please login to the form below

Not currently logged in
Email:
Password:

Patients still denied access to new drugs NICE approvals

Patients are still being denied access to NHS treatments despite winning approval byNICE, according to UK media reports

According UK media reports, patients are still being denied access to NHS treatments despite winning approval by the National Institute for Health and Clinical Excellence (NICE).

A Daily Mail report says that the UK government has given Primary Care Trusts (PCT) permission to refuse patients treatments, including a new type of therapy for diabetics as well as special surgery for colon cancer.

Guidelines currently state that novel treatments must be available within three months once approved by the agency.

A new report by the Health Select Committee will recommend a review of the way new treatments are approved.

9th January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics